Massive 3,000-Person study tracks hair loss Drug's Real-World safety
NCT ID NCT07152119
Summary
This study is monitoring the safety and effectiveness of Litfulo capsules in real-world patients with severe alopecia areata (patchy hair loss). It will follow 3,000 patients in Korea for up to 48 weeks to track any side effects and measure how much hair regrows. The goal is to understand how the medication performs outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ALOPECIA AREATA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer, Inc
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.